Who owns Essa Pharma Inc?

Tip: Access positions for across all investors

Analyze quarterly positions in Essa Pharma with up to 7 years of data, all consolidated into one spreadsheet

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Top investors of Essa Pharma stock

Who bought or sold Essa Pharma Inc this quarter?

There are no current stakeholders of Essa Pharma.

This is normal when the security:

  • Has been acquired or taken private
  • Has merged with another entity
  • Has changed its name and has a new CUSIP (and/or symbol)
  • Has been delisted and the ticker has changed

Please use Search to find the security you were looking for.

Who sold out of Essa Pharma?

Fund or Company Name Date Sold Shares Held Valued At
BVF Sep 2025 12M $2.2M
Soleus Capital Management Sep 2025 4.4M $833k
Pfizer Sep 2025 1.7M $320k
LMR Partners Sep 2025 541k $103k
Shay Capital Sep 2025 537k $103k
Susquehanna International Sep 2025 384k $73k
Two Sigma Investments Sep 2025 336k $64k
Two Sigma Advisers Sep 2025 215k $41k
Citadel Advisors Sep 2025 181k $35k
Jane Street Sep 2025 160k $31k
CSS Sep 2025 112k $21k
Virtu Financial Sep 2025 77k $15k
Yakira Capital Management Sep 2025 72k $14k
Skandinaviska Enskilda Banken AB Sep 2025 52k $9.9k
XTX Topco Sep 2025 46k $8.7k
Belvedere Trading Sep 2025 35k $6.7k
Beaumont Capital Management Sep 2025 28k $5.4k
Geode Capital Management Sep 2025 24k $4.6k
Simplex Trading Sep 2025 20k $3.0k
Bnp Paribas Arbitrage, Snc Sep 2025 9.8k $1.9k
BlackRock Sep 2025 7.1k $1.4k
Advisor Group Holdings Sep 2025 6.0k $1.4k
UBS Group Sep 2025 5.5k $1.8k
Atlantic Trust Sep 2025 2.5k $478.000000
Federation des caisses Desjardins du Quebec Sep 2025 2.1k $391.960000
TD Waterhouse Canada Sep 2025 900.00 $185.040000
Truvestments Capital Sep 2025 490.00 $93.982000
Barclays Sep 2025 355.00 $67.982500